Stephen Canon: Physicians in the US, especially those who operate in both fee-for-service and value-based payment models, may lose revenue in the short-term because it’s difficult to navigate both effectively.
Rex Mahnensmith: The US healthcare industry must overcome the tendency to overemphasize the importance of cost reduction. The industry must focus more on clinical best practices that automatically enable efficiency.
Johan Larsen: Healthcare professionals and administrators in the US are slow to adapt to change. Few have the agility, capability and resources necessary to stay current in this arena.
John Halamka: We don’t have the right data. My father died five years ago after living with multiple sclerosis for 23 years. We should have measured his pain, his gait and his muscle flexibility instead of his compliance with medications. Innovative devices and apps will enable us to gather patient-generated data and patient reports of outcomes much more easily.
Patricia Mechael: Healthcare reimbursement models don’t pay for all types of connected care. The good news is that this is changing. Recent reimbursement opportunities for remote patient monitoring in the US and other countries is a promising first step. Various countries are also implementing telemedicine strategies and policies. However, we need more rigorous studies (such as randomized control trials) that demonstrate the health impact of connected care approaches.
Dave Debronkart: Commercial players object when rules and regulations that ultimately enable value-based and patient-centric care change.
Kim Hodge: We need to be able to hold patients accountable for risky health behaviors and non-adherence. We also need a governing body to define value and enforce it.
Diane Bell: We need to change the culture of ‘professional knows best’ to focus more on what matters to individuals. The health system in Wales has started to adopt this mentality, but there are challenges related to collecting and using patient outcome data systematically throughout a patient’s course of treatment.
Bret Schroeder: One challenge is access to accurate and consistent data across multiple stakeholders to track, calculate, and report on the metrics that define value. Traditional measures of value compare outcomes versus cost, but they fail to incorporate causal factors, and they don’t consider patient satisfaction, access and/or consumer preferences – all of which are essential components of value-based healthcare. For example, in the US, patients value choice and access – neither of which is a consideration in traditional value measures.